Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
Y AnderssonL BergkvistJ FrisellJana de BonifacePublished in: The British journal of surgery (2021)
After 3 years, event-free survival was excellent in patients with breast cancer and sentinel node micrometastases despite omission of axillary lymph node dissection. Long-term follow-up and continued enrolment of patients having mastectomy, especially those not receiving adjuvant radiotherapy, are of utmost importance.
Keyphrases
- lymph node
- sentinel lymph node
- early stage
- free survival
- neoadjuvant chemotherapy
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- rectal cancer
- radical prostatectomy
- prostate cancer
- prognostic factors
- study protocol
- radiation therapy
- squamous cell carcinoma
- ultrasound guided
- clinical trial
- radiation induced
- phase ii
- sensitive detection
- open label